MLL1 is essential for the senescence-associated secretory phenotype

Genes & Development
Brian C CapellShelley L Berger

Abstract

Oncogene-induced senescence (OIS) and therapy-induced senescence (TIS), while tumor-suppressive, also promote procarcinogenic effects by activating the DNA damage response (DDR), which in turn induces inflammation. This inflammatory response prominently includes an array of cytokines known as the senescence-associated secretory phenotype (SASP). Previous observations link the transcription-associated methyltransferase and oncoprotein MLL1 to the DDR, leading us to investigate the role of MLL1 in SASP expression. Our findings reveal direct MLL1 epigenetic control over proproliferative cell cycle genes: MLL1 inhibition represses expression of proproliferative cell cycle regulators required for DNA replication and DDR activation, thus disabling SASP expression. Strikingly, however, these effects of MLL1 inhibition on SASP gene expression do not impair OIS and, furthermore, abolish the ability of the SASP to enhance cancer cell proliferation. More broadly, MLL1 inhibition also reduces "SASP-like" inflammatory gene expression from cancer cells in vitro and in vivo independently of senescence. Taken together, these data demonstrate that MLL1 inhibition may be a powerful and effective strategy for inducing cancerous growth arrest thro...Continue Reading

References

Oct 9, 1998·Genes & Development·J ZhuJ M Bishop
Sep 9, 1999·The Journal of Cell Biology·E P RogakouW M Bonner
Nov 28, 2002·Molecular Cell·Thomas A MilneJay L Hess
Apr 15, 2005·Nature·Vassilis G GorgoulisThanos D Halazonetis
Aug 5, 2005·Nature·Chrysiis MichaloglouDaniel S Peeper
Aug 2, 2006·The Journal of Biological Chemistry·Jean-Philippe CoppéChristian M Beauséjour
Dec 1, 2006·Nature·Raffaella Di MiccoFabrizio d'Adda di Fagagna
Jun 25, 2008·Nature Reviews. Cancer·Fabrizio d'Adda di Fagagna
Oct 7, 2009·Proceedings of the National Academy of Sciences of the United States of America·Arturo V OrjaloJudith Campisi
Nov 11, 2009·Proceedings of the National Academy of Sciences of the United States of America·Veronika JeneiTommy Andersson
Dec 10, 2009·The Journal of Cell Biology·Antonio CerqueiraMariano Barbacid
Jan 19, 2010·Annual Review of Pathology·Jean-Philippe CoppéJudith Campisi
May 7, 2010·Trends in Molecular Medicine·Adam FreundJudith Campisi
Nov 30, 2010·Nature Structural & Molecular Biology·Sayako Katada, Paolo Sassone-Corsi
Feb 16, 2011·The Journal of Cell Biology·Francis Rodier, Judith Campisi
Mar 8, 2011·Cell·Douglas Hanahan, Robert A Weinberg
Jun 28, 2011·Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society·Remi-Martin LabergePierre-Yves Desprez
Jan 21, 2012·Cancer Prevention Research·Carolyn AlgireMichael N Pollak
Apr 4, 2013·Science Signaling·Jianjiong GaoNikolaus Schultz
Jun 19, 2013·Nature Cell Biology·Juan Carlos AcostaJesús Gil

❮ Previous
Next ❯

Citations

Jun 4, 2016·Molecular Cell·Lauren N Booth, Anne Brunet
Oct 25, 2016·The Journal of Investigative Dermatology·Kanad Ghosh, Brian C Capell
Nov 2, 2016·The Journal of Cell Biology·Ana Guerrero, Jesús Gil
May 11, 2017·Nature Communications·Kévin ContrepoisCarl Mann
Jul 21, 2017·Cell Death & Disease·Changlin ZhangWuguo Deng
Jul 22, 2017·Nature Reviews. Drug Discovery·Bennett G ChildsJan M van Deursen
Dec 1, 2017·Genes·Timothy NacarelliRugang Zhang
Nov 9, 2017·The Journal of Cell Biology·Domhnall McHugh, Jesús Gil
Sep 10, 2017·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Li-Qin ChengDe-Pei Liu
Jan 9, 2019·Expert Opinion on Therapeutic Targets·Lena Lau, Gregory David
Jan 17, 2019·Physiological Reviews·Arianna CalcinottoAndrea Alimonti
Feb 3, 2019·Aging Cell·Alejandra Hernandez-SeguraMarco Demaria
Oct 5, 2017·Nature·Zhixun DouShelley L Berger
Apr 22, 2019·Biomolecules & Therapeutics·Hyun LimHyun Pyo Kim
Oct 3, 2019·Development·Muriel RhinnWilliam M Keyes
Oct 28, 2019·Biomolecules & Therapeutics·Minji BangChan Young Shin
Feb 23, 2020·Cells·Harikrishnareddy PaluvaiClaudio Brancolini
Nov 6, 2018·Aging·Na Yang, Payel Sen
Apr 20, 2018·British Journal of Cancer·Jose Mario Gonzalez-MeljemJuan Pedro Martinez-Barbera
Sep 29, 2019·International Journal of Molecular Sciences·Peter J ThompsonAnil Bhushan
Dec 20, 2019·Cellular & Molecular Immunology·Yangjing ZhaoGuangyong Peng
May 24, 2017·Proceedings of the National Academy of Sciences of the United States of America·Hui YangZhijian J Chen
Apr 3, 2018·The Journal of Clinical Investigation·Yossi Ovadya, Valery Krizhanovsky
Jun 27, 2019·Nature Reviews. Cancer·Douglas V FagetSheila A Stewart
Jul 2, 2020·Cells·Eleonora CianfloneDaniele Torella
Feb 15, 2018·Genes & Development·Enrique Lin-ShiaoBrian C Capell
Apr 3, 2018·The Journal of Clinical Investigation·Nicolás Herranz, Jesús Gil
Feb 3, 2019·Genes & Development·Adelyne Sue Li Chan, Masashi Narita
May 2, 2020·Biogerontology·Deisi L BragaMarcelo A Mori
Jun 26, 2020·Frontiers in Aging Neuroscience·Xiaojuan HanXingchun Gou
Aug 14, 2020·EMBO Reports·Nicolas MalaquinFrancis Rodier
Mar 20, 2020·Cell Death & Disease·Minhao ChenYunfeng Rui
May 26, 2017·Aging Cell·Sadiya S KhanDouglas E Vaughan
Dec 3, 2020·Genes & Development·Jodie Birch, Jesús Gil
Apr 22, 2016·Cancer Discovery·Nilgun TasdemirScott W Lowe
Jan 27, 2021·Cells·Dilara DemirciSerif Senturk
Dec 18, 2020·Nature Reviews. Molecular Cell Biology·Raffaella Di MiccoFabrizio d'Adda di Fagagna

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Ataxia telangiectasia

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Ataxia telangiectasia (MDS)

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.

Cell Cycle Pathways

Cell cycle is a complex process regulated by several signal transduction pathways and enzymes. Here is the latest research on regulation of cell cycle and cell cycle pathways.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.